鹿得医疗
(920278)
| 流通市值：6.11亿 | | | 总市值：10.80亿 |
| 流通股本：9864.53万 | | | 总股本：1.75亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 147,905,317.35 | 61,690,963.34 | 300,094,980.3 | 216,474,324.02 |
| 营业收入 | 147,905,317.35 | 61,690,963.34 | 300,094,980.3 | 216,474,324.02 |
| 二、营业总成本 | 148,651,204.57 | 64,342,817.65 | 286,397,898.4 | 201,297,903.75 |
| 营业成本 | 115,920,932.04 | 48,607,141.48 | 222,924,456.42 | 160,188,545.28 |
| 税金及附加 | 1,743,994.4 | 1,147,254.4 | 2,574,665.91 | 2,079,485.79 |
| 销售费用 | 11,731,169.15 | 5,671,021.76 | 25,037,996.3 | 17,490,308.3 |
| 管理费用 | 11,661,722.34 | 4,846,118.58 | 23,199,260.29 | 15,226,796.37 |
| 研发费用 | 5,631,654.05 | 2,485,348.48 | 14,841,260.51 | 9,526,381.69 |
| 财务费用 | 1,961,732.59 | 1,585,932.95 | -2,179,741.03 | -3,213,613.68 |
| 其中:利息费用 | 397,552.17 | 164,226.34 | 1,122,246.45 | 867,247.36 |
| 其中:利息收入 | 849,796.59 | 590,403.71 | 2,875,584.22 | 2,415,949.81 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 1,089,981.49 | 44,277.75 | 440,882.65 | 1,066,891.9 |
| 加:投资收益 | 2,785,539.38 | 2,421,258.38 | 2,843,824.45 | 500,503.03 |
| 资产减值损失(新) | -339,521.86 | -198,377.07 | 436,102.41 | 46,900.05 |
| 信用减值损失(新) | -172,928.9 | 632,787.41 | 2,228,760.49 | 1,932,697.08 |
| 其他收益 | 168,837.39 | 122,545.87 | 1,327,569.88 | 870,116.32 |
| 四、营业利润 | 2,786,020.28 | 370,638.03 | 20,974,221.78 | 19,593,528.65 |
| 加:营业外收入 | 657.79 | 40.74 | 50,999.3 | 46,863.69 |
| 减:营业外支出 | 57,983.78 | 14,408.99 | 285,169.59 | 274,194.83 |
| 五、利润总额 | 2,728,694.29 | 356,269.78 | 20,740,051.49 | 19,366,197.51 |
| 减:所得税费用 | -728,554.03 | -311,019.22 | 1,519,514.49 | 1,859,947.43 |
| 六、净利润 | 3,457,248.32 | 667,289 | 19,220,537 | 17,506,250.08 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 3,457,248.32 | 667,289 | 19,220,537 | 17,506,250.08 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 3,539,843.66 | 680,474.59 | 19,454,357.56 | 17,686,935 |
| 少数股东损益 | -82,595.34 | -13,185.59 | -233,820.56 | -180,684.92 |
| 扣除非经常损益后的净利润 | 2,517,899.31 | 547,100.52 | 17,050,666.56 | 16,242,048.25 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.02 | 0 | 0.11 | 0.1 |
| (二)稀释每股收益 | 0.02 | 0 | 0.11 | 0.1 |
| 八、其他综合收益 | -1,682.28 | -1,114.68 | -1,534.51 | -794.42 |
| 归属于母公司股东的其他综合收益 | -1,682.28 | -1,114.68 | -1,534.51 | -794.42 |
| 九、综合收益总额 | 3,455,566.04 | 666,174.32 | 19,219,002.49 | 17,505,455.66 |
| 归属于母公司股东的综合收益总额 | 3,538,161.38 | 679,359.91 | 19,452,823.05 | 17,686,140.58 |
| 归属于少数股东的综合收益总额 | -82,595.34 | -13,185.59 | -233,820.56 | -180,684.92 |
| 公告日期 | 2026-08-25 | 2026-04-28 | 2026-04-28 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |